Antibody Therapies Take the Spotlight as Covid-19 ‘Plan B’

(Bloomberg) -- An experimental antibody therapy to combat Covid-19 from Regeneron Pharmaceuticals Inc. got a shot of confidence from the U.S. government on Tuesday with a $450 million contract to s...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.